logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Anita K. Wagner

Boston Children's Hospital

40H指数
169论文数
8.3K被引数
收录论文 58
发表时间
logo
A nationwide register study of new outpatient medicines: trends in initial costs and medicine selection in Finland, 2011–2021全国性登记研究：芬兰2011—2021年新门诊药物的趋势、初始成本及药物选择
errBMC Health Services Research
IF3
err2026-09-26
err0
errOAAI
errKlaudia Kaustiala; Hanna Rättö; Kati Sarnola; Terhi Kurko; Anita K. Wagner; Hanna Koskinen
err分享
err收藏
Pediatric studies and labeling additions required by the US FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study2011年至2023年美国FDA批准的新药所需的儿科研究和标签补充：一项回顾性队列研究
errPLOS Medicine
IF9.9
err2025-12-17
err0
PREAI
errMcGonigle, Rylee; Naci, Huseyin; Siebert, Maximilian; Ouvina, Michelle; Gutierrez-Sacristan, Alba; Wagner, Anita K.; Bourgeois, Florence T.
err分享
err收藏
Assessment of Oral Anti-Cancer Medicines in Pediatric Patients Before the RACE Act, 2007-20212007-2021年《RACE法案》实施前儿童患者口服抗肿瘤药物评估
errThe Journal of Pediatrics
IF3.5
err2025-12-12
err0
PREAI
errMahnum Shahzad; Steven G. DuBois; Rebecca Costa; Stephanie Argetsinger; Dennis Ross-Degnan; Florence T. Bourgeois; Anita K. Wagner
err分享
err收藏
Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis2017年至2021年中国癌症药物审批的证据强度：一项回顾性分析
errlancet oncology
IF0
err2025-08-06
err0
PREAI
errYichen Zhang; Dingyi Chen; Mengyuan Fu; Luwen Shi; Huseyin Naci; Anita K Wagner; Joseph S Ross; Xiaodong Guan
err分享
err收藏
Patients deserve better information on new drugs
errBMJ-BRITISH MEDICAL JOURNAL
IF42.7
err2024-10-29
err1
PREAI
errDavis, Courtney; Wagner, Anita K.; Mintzes, Barbara; Scowcroft, Henry; Woloshin, Steven; Naci, Huseyin
err分享
err收藏
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway
errJOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
IF2.5
err2024-06-04
err2
errOAAI
errShahzad, Mahnum; Naci, Huseyin; Esselen, Katharine M.; Dottino, Joseph A.; Wagner, Anita K.
err分享
err收藏
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical bene fi t, 2001 - 2020
errLANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
err2024-04-01
err0
errOAAI
errWei, Yuxuan; Zhang, Yichen; Xu, Ziyue; Wang, Guoan; Zhou, Yue; Li, Huangqianyu; Shi, Luwen; Naci, Huseyin; Wagner, Anita K.; Guan, Xiaodong
err分享
err收藏
Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021
errBMJ GLOBAL HEALTH
IF6.1
err2023-09-28
err1
errOAAI
errZhou, Yue; Naci, Huseyin; Chen, Dingyi; Bai, Lin; Shi, Luwen; Guan, Xiaodong; Wagner, Anita Katharina
err分享
err收藏
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis
errLANCET REGIONAL HEALTH-AMERICAS
IF7.6
err2023-06-01
err11
errOAAI
errIvama-Brummell, Adriana M.; Marciniuk, Fernanda L.; Wagner, Anita K.; Osorio-de-Castro, Claudia G. S.; Vogler, Sabine; Mossialos, Elias; Tavares-de-Andrade, Carla L.; Naci, Huseyin
err分享
err收藏
Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe
errBMJ-BRITISH MEDICAL JOURNAL
IF42.7
err2023-03-29
err7
errOAAI
errDavis, Courtney; Wagner, Anita K.; Salcher-Konrad, Maximilian; Scowcroft, Henry; Mintzes, Barbara; Pokorny, Adrian M. J.; Lew, Jianhui; Naci, Huseyin
err分享
err收藏
Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway
errJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
err2023-03-07
err18
errOAAI
errShahzad, Mahnum; Naci, Huseyin; Wagner, Anita K.
err分享
err收藏
Newly approved cancer drugs in China - innovation and clinical benefit
errNATURE REVIEWS CLINICAL ONCOLOGY
IF82.2
err2023-01-16
err12
PREAI
errZhang, Yichen; Wagner, Anita K.; Guan, Xiaodong
err分享
err收藏
Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil
errBMJ GLOBAL HEALTH
IF6.1
err2022-03-11
err3
errOAAI
errIvama-Brummell, Adriana Mitsue; Wagner, Anita K.; Pepe, Vera Lucia Edais; Naci, Huseyin
err分享
err收藏
Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States
errINTERNATIONAL JOURNAL OF CANCER
IF4.7
err2021-10-06
err1
errOAAI
errZhang, Yichen; Katharina Wagner, Anita; Du, Haoxin; Han, Taisen; Gupta, Sumit; Denburg, Avram E.; Frazier, A. Lindsay; Guan, Xiaodong; Shi, Luwen
err分享
err收藏
The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
errBMJ GLOBAL HEALTH
IF6.1
err2021-07-15
err49
errOAAI
errZhang, Yichen; Wushouer, Haishaerjiang; Han, Sheng; Fu, Mengyuan; Guan, Xiaodong; Shi, Luwen; Wagner, Anita
err分享
err收藏
Forecasting essential childhood cancer drug need: An innovative model-based approach
errCANCER
IF5.1
err2021-04-12
err7
errOAAI
errHughes, Terence M.; Empringham, Brianna; Wagner, Anita K.; Ward, Zachary J.; Yeh, Jennifer; Gupta, Sumit; Frazier, A. Lindsay; Denburg, Avram E.
err分享
err收藏
Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
errCANCER COMMUNICATIONS
IF24.9
err2021-02-20
err3
errOAAI
errHuang, Tao; Wagner, Anita Katharina; Bai, Lin; Huang, Cong; Guan, Xiaodong; Shi, Luwen
err分享
err收藏
Efficacy and costs of spinal muscular atrophy drugs
errSCIENCE TRANSLATIONAL MEDICINE
IF14.6
err2020-11-11
err18
PREAI
errDarrow, Jonathan J.; Sharma, Monica; Shroff, Mansa; Wagner, Anita K.
err分享
err收藏
Article 3: 1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities
errJOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
IF2.5
err2020-09-01
err2
errOAAI
errTrap, Birna; Sembatya, Moses N.; Imi, Monica; Seru, Morries; Wagner, Anita K.; Ross-Degnan, Dennis
err分享
err收藏
Sales of anti-cancer medicines; China, Indonesia, Kazakhstan, Malaysia, Philippines and Thailand
errBULLETIN OF THE WORLD HEALTH ORGANIZATION
IF5.7
err2020-05-28
err6
errOAAI
errFerrario, Alessandra; Stephens, Peter; Guan, Xiaodong; Ross-Degnan, Dennis; Wagner, Anita
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
A
Arno Villringer
H 指数: 117 · 论文数: 2.0K
M
Marcel Tanner
H 指数: 97 · 论文数: 650
A
Aluísio J. D. Barros
H 指数: 96 · 论文数: 762
J
Jerry H. Gurwitz
H 指数: 95 · 论文数: 604
C
Craig C. Earle
H 指数: 89 · 论文数: 603
查看更多